H.R. 5231--the National Competitiveness Act of 1992: Hearings Before the Subcommittee on Technology and Competitiveness of the Committee on Science, Space, and Technology, U.S. House of Representatives, One Hundred Second Congress, Second Session, June 3, 4, 1992; Markups, June 24, July 1, August 5, 6, 11, 1992 |
Other editions - View all
Common terms and phrases
activities Administration advanced manufacturing Advanced Technology Program amendment American appropriate areas assistance authorized Award bill budget capital gains Chair Chairman clients Committee Competitive Enterprise Institute Congress consortia critical technologies DARPA Department of Commerce Director economic effective efforts engineering evaluation firms funding gentleman GREENFELD improve Innovation Institute of Standards investment issue laboratories legislation Lewis licensee Manufacturing Technology Centers ment million MTC program National Competitiveness Act NHTSA NIST nology NTIS operations outreach Panel paragraph participants percent private sector problem projects proposed qualified business research and development role SBIR Science Secretary of Commerce section 28 small business small companies Standards and Technology Subcommittee subsection subtitle tech technical Technology Administration Technology and Competitiveness technology development Technology Policy technology transfer Thank Tim Valentine tion Title U.S. companies United VALENTINE venture capital Walker
Popular passages
Page 339 - Eager to douse the dangers of asbestos, the agency inadvertently actually may increase the risk of injury Americans face. The EPA's explicit failure to consider the toxicity of likely substitutes thus deprives its order of a reasonable basis." Corrosion Proof Fittings V. EPA. 947 F.2d 1201, 1221 (5th Cir. 1991). There is no magic cure-all for such administrative failures, but if agencies are required to analyze the full scope of consequences from their actions, they may do better at avoiding the...
Page 244 - Modest Leverage to Date Early stages of contacts with other states; promotion of industrial networks; contacts with large number of companies; good assessment tools with general applicability (now working on computer version). 20 NORTHEAST MANUFACTURING TECHNOLOGY CENTER Origin/Foundation Division of the Center for Manufacturing Productivity and Technology Transfer at Rensselaer Polytechnic Institute (RPI), in Troy, New York. Operations Staff: Pan-time staff from Rensselaer and Hudson Valley Community...
Page 494 - If not, the chair will put the question. All those in favor of the motion will signify by saying aye.
Page 341 - FDA's history, I am unable to find a single instance where a congressional committee investigated the failure of FDA to approve a new drug. But, the times when hearings have been held to criticize our approval of new drugs have been so frequent that we aren't able to count them....
Page 465 - No funds appropriated pursuant to this Act may be expended by an entity unless the entity agrees that in expending the assistance the entity will comply with sections 2 through 4 of the Act of March 3, 1933 (41 USC lOa-lOc, popularly known as the "Buy American Act").] [SEC.
Page 20 - Directors of the Office of Management and Budget and the Office of Science and Technology Policy jointly emphasized the administration's policy that even under stringent planning ceilings, long-term defense needs must receive priority consideration.
Page 671 - All those in favor of the amendment, signify by saying aye. ' [Chorus of ayes.] Chairman FASCELL. All those opposed, no. [Chorus of noes.] Chairman FASCELL. It appears that the noes have it. The noes have it, and the amendment is not agreed to.
Page 111 - The laboratory also works on measurement and standardization problems in computer science; electronics and electrical engineering; building and construction technology; automation and manufacturing; chemical engineering; and fire prevention, detection and control NIST also manages several extramural programs including a set of centers for transfer of manufacturing technology, and a program of sponsored research and development in advanced technology. Dr. Lyons spent 18 years with the Monsanto Company...
Page 341 - FDA history, we are unable to find a single instance where a Congressional Committee investigated the failure of FDA to approve a new drug. But, the times when hearings have been held to criticize our approval of a new drug have been so frequent that we have not been able to count them. The message to FDA staff could not be clearer.
Page 152 - The magnitude of the problem is such that we cannot rely upon normal forces to maintain our advantage in technology. We are at the forefront in many technological areas. The costs of breaking new ground in some of these areas are high — higher than private companies or perhaps even private consortia are able to justify because the risks are so great. We have...